Cargando…
Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review
BACKGROUND: Lynch syndrome is an autosomal dominant inherited disease caused by germline mutations in mismatch repair genes. Analysis for microsatellite instability (MSI) and immunohistochemistry (IHC) of protein expressions of disease-associated genes is used to screen for Lynch syndrome in endomet...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963021/ https://www.ncbi.nlm.nih.gov/pubmed/29783979 http://dx.doi.org/10.1186/s12885-018-4489-0 |
_version_ | 1783324973103841280 |
---|---|
author | Yokoyama, Takanori Takehara, Kazuhiro Sugimoto, Nao Kaneko, Keika Fujimoto, Etsuko Okazawa-Sakai, Mika Okame, Shinichi Shiroyama, Yuko Yokoyama, Takashi Teramoto, Norihiro Ohsumi, Shozo Saito, Shinya Imai, Kazuho Sugano, Kokichi |
author_facet | Yokoyama, Takanori Takehara, Kazuhiro Sugimoto, Nao Kaneko, Keika Fujimoto, Etsuko Okazawa-Sakai, Mika Okame, Shinichi Shiroyama, Yuko Yokoyama, Takashi Teramoto, Norihiro Ohsumi, Shozo Saito, Shinya Imai, Kazuho Sugano, Kokichi |
author_sort | Yokoyama, Takanori |
collection | PubMed |
description | BACKGROUND: Lynch syndrome is an autosomal dominant inherited disease caused by germline mutations in mismatch repair genes. Analysis for microsatellite instability (MSI) and immunohistochemistry (IHC) of protein expressions of disease-associated genes is used to screen for Lynch syndrome in endometrial cancer patients. When losses of both MLH1 and PMS2 proteins are observed by IHC, MLH1 promoter methylation analysis is conducted to distinguish Lynch syndrome-associated endometrial cancer from sporadic cancer. CASE PRESENTATION: Here we report a woman who developed endometrial cancer at the age of 49 years. She had a family history of colorectal cancer (first-degree relative aged 52 years) and stomach cancer (second-degree relative with the age of onset unknown). No other family history was present, and she failed to meet the Amsterdam II criteria for the diagnosis of Lynch syndrome. Losses of MLH1 and PMS2, but not MSH2 and MSH6, proteins were observed by IHC in endometrial cancer tissues. Because MLH1 promoter hypermethylation was detected in endometrial cancer tissue samples, the epigenetic silencing of MLH1 was suspected as the cause of the protein loss. However, because of the early onset of endometrial cancer and the positive family history, a diagnosis of Lynch syndrome was also suspected. Therefore, we provided her with genetic counseling. After obtaining her consent, MLH1 promoter methylation testing and genetic testing of peripheral blood were performed. MLH1 promoter methylation was not observed in peripheral blood. However, genetic testing revealed a large deletion of exon 5 in MLH1; thus, we diagnosed the presence of Lynch syndrome. CONCLUSIONS: Both MLH1 germline mutation and MLH1 promoter hypermethylation may be observed in endometrial cancer. Therefore, even if MLH1 promoter hypermethylation is detected, a diagnosis of Lynch syndrome cannot be excluded. |
format | Online Article Text |
id | pubmed-5963021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-59630212018-06-25 Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review Yokoyama, Takanori Takehara, Kazuhiro Sugimoto, Nao Kaneko, Keika Fujimoto, Etsuko Okazawa-Sakai, Mika Okame, Shinichi Shiroyama, Yuko Yokoyama, Takashi Teramoto, Norihiro Ohsumi, Shozo Saito, Shinya Imai, Kazuho Sugano, Kokichi BMC Cancer Case Report BACKGROUND: Lynch syndrome is an autosomal dominant inherited disease caused by germline mutations in mismatch repair genes. Analysis for microsatellite instability (MSI) and immunohistochemistry (IHC) of protein expressions of disease-associated genes is used to screen for Lynch syndrome in endometrial cancer patients. When losses of both MLH1 and PMS2 proteins are observed by IHC, MLH1 promoter methylation analysis is conducted to distinguish Lynch syndrome-associated endometrial cancer from sporadic cancer. CASE PRESENTATION: Here we report a woman who developed endometrial cancer at the age of 49 years. She had a family history of colorectal cancer (first-degree relative aged 52 years) and stomach cancer (second-degree relative with the age of onset unknown). No other family history was present, and she failed to meet the Amsterdam II criteria for the diagnosis of Lynch syndrome. Losses of MLH1 and PMS2, but not MSH2 and MSH6, proteins were observed by IHC in endometrial cancer tissues. Because MLH1 promoter hypermethylation was detected in endometrial cancer tissue samples, the epigenetic silencing of MLH1 was suspected as the cause of the protein loss. However, because of the early onset of endometrial cancer and the positive family history, a diagnosis of Lynch syndrome was also suspected. Therefore, we provided her with genetic counseling. After obtaining her consent, MLH1 promoter methylation testing and genetic testing of peripheral blood were performed. MLH1 promoter methylation was not observed in peripheral blood. However, genetic testing revealed a large deletion of exon 5 in MLH1; thus, we diagnosed the presence of Lynch syndrome. CONCLUSIONS: Both MLH1 germline mutation and MLH1 promoter hypermethylation may be observed in endometrial cancer. Therefore, even if MLH1 promoter hypermethylation is detected, a diagnosis of Lynch syndrome cannot be excluded. BioMed Central 2018-05-21 /pmc/articles/PMC5963021/ /pubmed/29783979 http://dx.doi.org/10.1186/s12885-018-4489-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Yokoyama, Takanori Takehara, Kazuhiro Sugimoto, Nao Kaneko, Keika Fujimoto, Etsuko Okazawa-Sakai, Mika Okame, Shinichi Shiroyama, Yuko Yokoyama, Takashi Teramoto, Norihiro Ohsumi, Shozo Saito, Shinya Imai, Kazuho Sugano, Kokichi Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review |
title | Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review |
title_full | Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review |
title_fullStr | Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review |
title_full_unstemmed | Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review |
title_short | Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review |
title_sort | lynch syndrome-associated endometrial carcinoma with mlh1 germline mutation and mlh1 promoter hypermethylation: a case report and literature review |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963021/ https://www.ncbi.nlm.nih.gov/pubmed/29783979 http://dx.doi.org/10.1186/s12885-018-4489-0 |
work_keys_str_mv | AT yokoyamatakanori lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT takeharakazuhiro lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT sugimotonao lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT kanekokeika lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT fujimotoetsuko lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT okazawasakaimika lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT okameshinichi lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT shiroyamayuko lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT yokoyamatakashi lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT teramotonorihiro lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT ohsumishozo lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT saitoshinya lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT imaikazuho lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview AT suganokokichi lynchsyndromeassociatedendometrialcarcinomawithmlh1germlinemutationandmlh1promoterhypermethylationacasereportandliteraturereview |